Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.61 |
| ▸ | LPL | P06858 | 9/20 | 0.61 |
| ▸ | P4HB | P07237 | 1/20 | 0.39 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | SNCA | P37840 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28718456 | 0.92 | LIPG (0.73) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL21065677 | 0.92 | LIPG (0.73) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL22898975 | 0.91 | LIPG (0.50) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL22295108 | 0.88 | LIPG (0.71) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL19106581 | 0.88 | LIPG (0.71) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL23327826 | 0.88 | LIPG (0.80) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL20995884 | 0.88 | LIPG (0.80) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL23327902 | 0.88 | LIPG (0.80) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL22639304 | 0.88 | LIPG (0.80) | LIPGLPLP4HBSNCADGAT1 | |
| SCHEMBL23082128 | 0.88 | LIPG (0.80) | LIPGLPLP4HBSNCADGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3766875-B1 | COMPOUND AND AN ORGANIC SEMICONDUCTING LAYER, AN ORGANIC ELECTRONIC DEVICE, A DISPLAY DEVICE AND A LIGHTING DEVICE COMPRISING THE SAME | NOVALED GMBH (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-20220165958-A1 | Compound and an Organic Semiconducting Layer, an Organic Electronic Device, a Display Device and a Lighting Device Comprising the Same | NOVALED GMBH (DE) | 2022-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220165958-A1 | Compound and an Organic Semiconducting Layer, an Organic Electronic Device, a Display Device and a Lighting Device Comprising the Same | OCIAD1, AOX1, OCIAD2 | LIPG 609/4885LPL 222/4885P4HB 1533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.